Renaissance Technologies LLC
- SEC CIK
- 0001037389
- Latest filing
- Aug 13, 2026
The latest 13F from Renaissance Technologies LLC covers Q2 2026 (filed Aug 13, 2026): 3,140 long positions worth $72.6B. The top 10 holdings make up 12.0% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 2.0%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.
What changed in Q2 2026
Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.
- New
- 550
- Est. +$7.34B
- Added
- 1082
- Est. +$14.7B
- Reduced
- 1502
- Est. −$18.0B
- Sold out
- 623
- Est. −$5.45B
Top 5 holdings
Share of this quarter's portfolio value
Biggest buys
New and added positions, by estimated amount bought
Largest weight increases
New and added positions, by percentage points of the portfolio gained
Biggest sells
Reduced and sold-out positions, by estimated amount sold
Largest weight decreases
Reduced and sold-out positions, by percentage points of the portfolio lost
Metrics
13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.
- Portfolio value
- $72.6B
- +$8.69B (+13.6%) vs. prior quarter
- Positions
- 3,140
- −73 vs. prior quarter
- Top 10 concentration
- 12.0%
- Top 10 as share of value
- Turnover
- 32.3%
- Q2 2026, one quarter
- Average holding period
- 11.5 quarters
- Weighted by value
How these are calculated
- Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
- Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
- Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
- Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.
13F filings by quarter
22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.
Peak $85.2B (Q1 2022)
| Quarter | Filed | Positions | Value | Top 3 holdings | Changes | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | 3,140 | $72.6B | NVDAMETAINTC | vs. Q1 2026 | SEC |
| Q1 2026 | May 14, 2026 | 3,213 | $63.9B | UTHRPLTRAAPL | vs. Q4 2025 | SEC |
| Q4 2025 | Feb 12, 2026 | 3,185 | $64.5B | PLTRUTHRMU | vs. Q3 2025 | SEC |
| Q3 2025 | Nov 13, 2025 | 3,457 | $75.8B | PLTRNVDARBLX | vs. Q2 2025 | SEC |
| Q2 2025 | Aug 13, 2025 | 3,522 | $75.2B | PLTRNVDAHOOD | vs. Q1 2025 | SEC |
| Q1 2025 | May 14, 2025 | 3,406 | $66.1B | PLTRVRSNCORT | vs. Q4 2024 | SEC |
| Q4 2024 | Feb 13, 2025 | 3,533 | $67.6B | PLTRUTHRNVO | vs. Q3 2024 | SEC |
| Q3 2024 | Nov 13, 2024 | 3,484 | $66.5B | PLTRNVOUTHR | vs. Q2 2024 | SEC |
| Q2 2024 | Aug 9, 2024 | 3,444 | $59.0B | NVOPLTRNVDA | vs. Q1 2024 | SEC |
| Q1 2024 | May 13, 2024 | 3,659 | $63.6B | NVOPLTRMETA | vs. Q4 2023 | SEC |
| Q4 2023 | Feb 13, 2024 | 3,683 | $64.6B | NVOUBERNVDA | vs. Q3 2023 | SEC |
| Q3 2023 | Nov 14, 2023 | 3,611 | $58.7B | NVOAAPLPLTR | vs. Q2 2023 | SEC |
| Q2 2023 | Aug 11, 2023 | 3,864 | $69.4B | NVOMETAAAPL | vs. Q1 2023 | SEC |
| Q1 2023 | May 12, 2023 | 3,924 | $75.4B | NVOAMZNGILD | vs. Q4 2022 | SEC |
| Q4 2022 | Feb 13, 2023 | 4,073 | $73.1B | NVOAMZNAAPL | vs. Q3 2022 | SEC |
| Q3 2022 | Nov 14, 2022 | 3,976 | $70.7B | NVOMSFTABNB | vs. Q2 2022 | SEC |
| Q2 2022 | Aug 12, 2022 | 4,173 | $84.5B | NVOMSFTMETA | vs. Q1 2022 | SEC |
| Q1 2022 | May 13, 2022 | 4,032 | $85.2B | NVOTSLAKR | vs. Q4 2021 | SEC |
| Q4 2021 | Feb 11, 2022 | 3,860 | $80.4B | NVOTEAMVRSN | vs. Q3 2021 | SEC |
| Q3 2021 | Nov 12, 2021 | 3,414 | $77.4B | NVOTEAMVRSN | vs. Q2 2021 | SEC |
| Q2 2021 | Aug 13, 2021 | 3,406 | $80.1B | NVOVRSNZM | vs. Q1 2021 | SEC |
| Q1 2021 | May 13, 2021 | 3,258 | $80.4B | NVOVRSNZM | – | SEC |
13D and 13G filings
Companies where Renaissance Technologies LLC reports owning 5% or more on Schedule 13D or 13G, and its latest filings.
Current stakes of 5% or more
20 companies, largest stake first.
| Company | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| JVACoffee Holding Co Inc | 13G/A | 7.77%443.8K shares | +1.08 ppfrom 6.69% | Feb 11, 20216 filings | Nov 13, 2025 | SEC |
| MEDMedifast Inc | 13G/A | 6.96%773.7K shares | −1.13 ppfrom 8.09% | Feb 11, 20217 filings | May 14, 2026 | SEC |
| MOMOHello Group Inc. | 13G/A | 6.56%7.82M shares | +1.43 ppfrom 5.13% | Feb 11, 20217 filings | Feb 12, 2026 | SEC |
| RCMTRCM Technologies, Inc. | 13G/A | 6.39%485.5K shares | – | Feb 11, 20215 filings | Feb 13, 2025 | SEC |
| WINAWinmark Corp | 13G | 6.21%220.5K shares | +1.26 ppfrom 4.95% | Feb 11, 20214 filings | Aug 13, 2025 | SEC |
| ETSYEtsy Inc | 13G/A | 6.09%6.00M shares | −1.59 ppfrom 7.68% | May 14, 20253 filings | Nov 13, 2025 | SEC |
| XBIOXenetic Biosciences, Inc. | 13G/A | 6.00%137.4K shares | −1.79 ppfrom 7.79% | Feb 12, 20262 filings | May 14, 2026 | SEC |
| PRDOPerdoceo Education Corp | 13G/A | 5.68%3.65M shares | – | Feb 11, 20215 filings | Feb 12, 2026 | SEC |
| TLYSTilly's, Inc. | 13G | 5.66%1.31M shares | – | Feb 11, 20214 filings | Aug 13, 2026 | SEC |
| INVAInnoviva, Inc. | 13G/A | 5.63%4.21M shares | −1.93 ppfrom 7.56% | Feb 11, 20217 filings | Feb 12, 2026 | SEC |
| UTMDUtah Medical Products Inc | 13G/A | 5.52%175.8K shares | −1.18 ppfrom 6.70% | Feb 11, 20216 filings | Aug 13, 2026 | SEC |
| LFVNLifevantage Corp | 13G/A | 5.31%669.4K shares | – | Feb 11, 20215 filings | Aug 13, 2026 | SEC |
| PETSPetmed Express Inc | 13G/A | 5.29%1.13M shares | – | Feb 11, 20214 filings | Aug 13, 2026 | SEC |
| CVGICommercial Vehicle Group, Inc. | 13G | 5.20%1.96M shares | +0.24 ppfrom 4.96% | Feb 11, 20216 filings | Aug 13, 2026 | SEC |
| USNAUsana Health Sciences Inc | 13G/A | 5.19%958.5K shares | – | Feb 11, 20215 filings | Aug 13, 2026 | SEC |
| SPOKSpok Holdings, Inc | 13G | 5.13%1.06M shares | – | Feb 11, 20215 filings | Aug 13, 2025 | SEC |
| BOLTBolt Biotherapeutics, Inc. | 13G | 5.13%98.6K shares | New | Aug 13, 20261 filing | Aug 13, 2026 | SEC |
| SFIXStitch Fix, Inc. | 13G | 5.08%6.00M shares | +0.17 ppfrom 4.91% | Nov 13, 20243 filings | Aug 13, 2026 | SEC |
| TZOOTravelzoo | 13G | 5.07%602.5K shares | New | Nov 13, 20241 filing | Nov 13, 2024 | SEC |
| GASSStealthGas Inc. | 13G | 5.02%1.85M shares | +0.21 ppfrom 4.81% | Feb 11, 20216 filings | Aug 13, 2025 | SEC |
Latest filings
850 filings on file made by Renaissance Technologies LLC or listing it as a reporting person; the latest 20 are shown.
| Company | Filed (ET) | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| UTMDUtah Medical Products Inc | Aug 13, 20264:25 PM ET | 13G/A | 5.52%175.8K shares | −1.18 ppfrom 6.70% | Jun 30, 2026 | SEC |
| USNAUsana Health Sciences Inc | Aug 13, 20264:25 PM ET | 13G/A | 5.19%958.5K shares | – | Jun 30, 2026 | SEC |
| TLYSTilly's, Inc. | Aug 13, 20264:24 PM ET | 13G | 5.66%1.31M shares | – | Jun 1, 2026 | SEC |
| SFIXStitch Fix, Inc. | Aug 13, 20264:24 PM ET | 13G | 5.08%6.00M shares | +0.17 ppfrom 4.91% | Jun 5, 2026 | SEC |
| PETSPetmed Express Inc | Aug 13, 20264:23 PM ET | 13G/A | 5.29%1.13M shares | – | Jun 30, 2026 | SEC |
| LFVNLifevantage Corp | Aug 13, 20264:23 PM ET | 13G/A | 5.31%669.4K shares | – | Apr 1, 2026 | SEC |
| HLFHerbalife Ltd. | Aug 13, 20264:23 PM ET | 13G/A | 4.79%5.02M shares | −0.65 ppfrom 5.44%Below 5% | Apr 1, 2026 | SEC |
| GPRKGeoPark Ltd | Aug 13, 20264:22 PM ET | 13G/A | 4.55%2.95M shares | –Below 5% | Apr 1, 2026 | SEC |
| EBFEnnis, Inc. | Aug 13, 20264:22 PM ET | 13G/A | 4.87%1.23M shares | –Below 5% | Jun 30, 2026 | SEC |
| CVGICommercial Vehicle Group, Inc. | Aug 13, 20264:21 PM ET | 13G | 5.20%1.96M shares | +0.24 ppfrom 4.96% | Jun 29, 2026 | SEC |
| CORTCorcept Therapeutics Inc | Aug 13, 20264:20 PM ET | 13G/A | 4.90%5.26M shares | −0.57 ppfrom 5.47%Below 5% | Apr 1, 2026 | SEC |
| BOLTBolt Biotherapeutics, Inc. | Aug 13, 20264:20 PM ET | 13G | 5.13%98.6K shares | New | Jun 24, 2026 | SEC |
| APEIAmerican Public Education Inc | Aug 13, 20264:19 PM ET | 13G/A | 4.96%910.6K shares | −0.51 ppfrom 5.47%Below 5% | Apr 28, 2026 | SEC |
| XBIOXenetic Biosciences, Inc. | May 14, 20264:47 PM ET | 13G/A | 6.00%137.4K shares | −1.79 ppfrom 7.79% | Mar 31, 2026 | SEC |
| WNEBWestern New England Bancorp, Inc. | May 14, 20264:47 PM ET | 13G/A | 4.94%1.00M shares | –Below 5% | Mar 31, 2026 | SEC |
| WWayfair Inc. | May 14, 20264:47 PM ET | 13G/A | 4.54%4.97M shares | −0.52 ppfrom 5.06%Below 5% | Mar 31, 2026 | SEC |
| MEDMedifast Inc | May 14, 20264:47 PM ET | 13G/A | 6.96%773.7K shares | −1.13 ppfrom 8.09% | Jan 2, 2026 | SEC |
| LQDTLiquidity Services Inc | May 14, 20264:46 PM ET | 13G/A | 3.96%1.50M shares | −1.32 ppfrom 5.28%Below 5% | Mar 31, 2026 | SEC |
| IRWDIronwood Pharmaceuticals Inc | May 14, 20264:45 PM ET | 13G/A | 4.90%8.06M shares | −0.47 ppfrom 5.37%Below 5% | Mar 31, 2026 | SEC |
| FONRFonar Corp | May 14, 20264:45 PM ET | 13G/A | 0.02%1.12K shares | −5.07 ppfrom 5.09%Below 5% | Mar 31, 2026 | SEC |